ArQule Message Board - Msg: 3327514

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ahhaha who wrote (154)	2/3/1998 2:17:00 AM
From: William Nelson	Read Replies (1) of 399

Well, I don't know that they have "everything bagged", but I think they must be doing something somewhat sophisticated or their partners (professional biochemists) would not pay them money and the patent office would not issue them patents. To me the most positive sign is the 2nd renewal from Abbot labs. The most negative sign is the lack of contracts from the big pharmas. One new partner and a patent on their core methodology this month... this is surely positive news. Stock has already responded.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next